Amundi’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
12,111
-232
-2% -$5.31K ﹤0.01% 1908
2026
Q1
$272K Buy
+12,343
New +$215K ﹤0.01% 1777
2025
Q3
Sell
-171,680
Closed -$2.19M 1608
2025
Q2
$2.19M Buy
171,680
+171,317
+47,195% +$1.93M ﹤0.01% 1068
2025
Q1
$4.14K Buy
363
+48
+15% +$797 ﹤0.01% 1922
2024
Q4
$5.64K Sell
315
-33,687
-99% -$655K ﹤0.01% 1936
2024
Q3
$664K Buy
+34,002
New +$695K ﹤0.01% 1371
2023
Q2
Sell
-346,301
Closed -$9.95M 2044
2023
Q1
$9.95M Sell
346,301
-422,384
-55% -$13.9M 0.01% 845
2022
Q4
$25.3M Sell
768,685
-550,477
-42% -$16.5M 0.01% 651
2022
Q3
$36.8M Buy
1,319,162
+883,420
+203% +$29.1M 0.02% 567
2022
Q2
$13.5M Buy
435,742
+147,866
+51% +$5.44M 0.01% 709
2022
Q1
$9.1M Buy
287,876
+166,570
+137% +$5.21M 0.01% 837
2021
Q4
$4.38M Buy
+121,306
New +$3.78M ﹤0.01% 1025

Other funds holding CC

Amundi's CC Position: Q2 2026 in Review

Amundi reduced its Chemours (CC) stake by 1.9% in Q2 2026, selling an estimated $5.31K and leaving 12,111 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Amundi first reported a position in CC in Q4 2021 and has held it in 12 quarters since. The position peaked at $36.8M in Q3 2022. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Amundi held 12,111 shares of Chemours worth $249K as of Q2 2026.
  • Amundi sold 232 Chemours shares in Q2 2026, an estimated $5.31K.
  • Chemours made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1908 holding.
  • Amundi first reported a position in Chemours in Q4 2021 and has held it in 12 quarters since.
  • Amundi's Chemours position peaked at $36.8M in Q3 2022.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.